Two Sigma Investments, LP Harrow Health, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 25,781 shares of HROW stock, worth $904,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,781
Holding current value
$904,397
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$20.85 - $46.47 $537,533 - $1.2 Million
25,781 New
25,781 $1.16 Million
Q1 2024

May 15, 2024
SELL
$9.3 - $13.23 $52,256 - $74,339
-5,619 Reduced 10.25%
49,220 $651,000
Q4 2023

Feb 14, 2024
SELL
$8.1 - $16.36 $267,567 - $540,419
-33,033 Reduced 37.59%
54,839 $614,000
Q3 2023

Nov 14, 2023
SELL
$14.03 - $22.08 $805,322 - $1.27 Million
-57,400 Reduced 39.51%
87,872 $1.26 Million
Q2 2023

Aug 14, 2023
SELL
$17.37 - $28.08 $2.26 Million - $3.65 Million
-129,875 Reduced 47.2%
145,272 $2.77 Million
Q1 2023

May 15, 2023
BUY
$13.84 - $21.46 $765,836 - $1.19 Million
55,335 Added 25.17%
275,147 $5.82 Million
Q4 2022

Feb 14, 2023
BUY
$10.28 - $14.78 $1.08 Million - $1.56 Million
105,419 Added 92.16%
219,812 $3.24 Million
Q3 2022

Nov 14, 2022
BUY
$6.57 - $24.88 $30,504 - $115,517
4,643 Added 4.23%
114,393 $1.38 Million
Q2 2022

Aug 15, 2022
BUY
$5.75 - $7.74 $179,359 - $241,433
31,193 Added 39.71%
109,750 $799,000
Q1 2022

May 16, 2022
SELL
$6.77 - $8.66 $359,107 - $459,361
-53,044 Reduced 40.31%
78,557 $536,000
Q4 2021

Feb 14, 2022
SELL
$8.5 - $12.0 $903,533 - $1.28 Million
-106,298 Reduced 44.68%
131,601 $1.14 Million
Q3 2021

Nov 15, 2021
SELL
$6.99 - $10.6 $519,182 - $787,315
-74,275 Reduced 23.79%
237,899 $2.16 Million
Q2 2021

Aug 16, 2021
BUY
$6.68 - $11.07 $317,801 - $526,655
47,575 Added 17.98%
312,174 $2.9 Million
Q1 2021

May 17, 2021
BUY
$6.26 - $11.03 $591,645 - $1.04 Million
94,512 Added 55.57%
264,599 $1.79 Million
Q4 2020

Feb 16, 2021
BUY
$4.76 - $6.93 $26,527 - $38,620
5,573 Added 3.39%
170,087 $1.17 Million
Q3 2020

Nov 16, 2020
BUY
$4.71 - $7.36 $685,747 - $1.07 Million
145,594 Added 769.52%
164,514 $920,000
Q2 2020

Aug 14, 2020
BUY
$3.61 - $6.47 $68,301 - $122,412
18,920 New
18,920 $99,000
Q3 2019

Nov 14, 2019
SELL
$4.89 - $8.0 $280,969 - $459,664
-57,458 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$4.2 - $8.7 $312,559 - $647,445
-74,419 Reduced 56.43%
57,458 $500,000
Q1 2019

May 15, 2019
BUY
$4.75 - $7.1 $626,415 - $936,326
131,877 New
131,877 $657,000

Others Institutions Holding HROW

# of Institutions
177
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $950M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email